MORE TO EXPLORE
Get expert insights and real-world perspectives from leading voices in the industry to help you make more informed decisions.
The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Media & Resources
With the Delta variant contributing to a surge in new cases across the country even as over half the population has been vaccinated, the COVID-19 pandemic is still a force to be reckoned with in the United States. While most people recover from a COVID infection within a few weeks, incidences of Post-Acute Sequelae of SARS-CoV-2 infection or PASC, otherwise known as "Long COVID," are alarmingly increasing. Symptoms of PASC commonly include cognitive impairment or "brain fog," chest pain and palpitations, shortness of breath, fatigue, and joint pain. These symptoms may be new or persistent, arising up to four weeks after the initial illness. Two recent publications from the Journal of the American Medical Association report that 3 to 10 million Americans experience these symptoms, regardless of duration and intensity of original COVID infection. A new study from The American Academy of Physical Medicine and Rehabilitation (AAPM&R) details PASC cases by state. Using COVID-19 data from Johns Hopkins University as well as U.S. census data, the AAPM&R study assumes that up to 30% of surviving COVID-19 cases result in PASC. "We must act now to form and implement a national crisis management plan that will help Americans impacted by PASC not only survive COVID-19 but regain their quality of life and return to being active members of their communities," says AAPM&R President Stuart M. Weinstein, MD, FAAPMR. The AAPM&R represents more than 10,000 physiatrists, or specialists in physical medicine and rehabilitation. They treat a variety of medical conditions that affect the brain, nerves, muscles and tendons. See our slideshow above for the states with the most and least PASC cases, and click here for the full study.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Sponsored by Imagine360
The Time for Reference-Based Pricing: Debunking Myths & Revealing New Opportunities
